0001623919-16-000058.txt : 20160331
0001623919-16-000058.hdr.sgml : 20160331
20160331161828
ACCESSION NUMBER: 0001623919-16-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160329
FILED AS OF DATE: 20160331
DATE AS OF CHANGE: 20160331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EndoChoice Holdings, Inc.
CENTRAL INDEX KEY: 0001623919
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 900886803
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11810 WILLS ROAD
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
BUSINESS PHONE: 888-682-3636
MAIL ADDRESS:
STREET 1: 11810 WILLS ROAD
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
FORMER COMPANY:
FORMER CONFORMED NAME: ECPM Holdings, LLC
DATE OF NAME CHANGE: 20141031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilreath Mark
CENTRAL INDEX KEY: 0001643821
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37414
FILM NUMBER: 161543495
MAIL ADDRESS:
STREET 1: 11810 WILLS ROAD
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
4
1
wf-form4_145945549752071.xml
FORM 4
X0306
4
2016-03-29
0
0001623919
EndoChoice Holdings, Inc.
GI
0001643821
Gilreath Mark
C/O ENDOCHOICE HOLDINGS, INC.
11405 OLD ROSWELL ROAD
ALPHARETTA
GA
30009
1
1
0
0
Chief Executive Officer
Common stock, par value $0.001 per share
74755
I
By Mark Gregory Gilreath Irrevocable Trust
Common stock, par value $0.001 per share
12243
I
By Entrust Georgia, LLC for the benefit of Mark G. Gilreath
Common stock, par value $0.001 per share
3200
I
By Spouse
Common stock, par value $0.001 per share
1818
I
By Daughter
Common stock, par value $0.001 per share
2016-03-29
4
A
0
32957
0
A
786207
D
Employee Stock Option (right to buy)
5.31
2016-03-29
4
A
0
71645
0
A
2026-03-29
Common stock, par value $0.001 per share
71645.0
71645
D
These shares represent an award of restricted stock units that will be settled in common stock upon vesting. The restricted stock units will vest over a four-year period with the first 25% vesting on March 29, 2017 and the remainder vesting ratably on the 29th of each month thereafter for a period of 36 months.
The total direct shares shown include 280,796 time-vesting restricted stock and/or unit award shares.
This stock option will vest over a four-year period with the first 25% vesting on March 29, 2017 and the remainder vesting ratably on the 29th of each month thereafter for a period of 36 months.
/s/ James B. Young, Jr., under Power of Attorney for Mark G. Gilreath
2016-03-31